Meth makers to be foiled by jelly

Specialty drugmaker Highland Pharmaceuticals says it's found a way to halt the production of meth cookers. The St. Louis company has developed a chemical lock of sorts that prevents meth-makers from extracting the "API" pseudoephedrine from common cold and allergy drugs such as Sudafed and Mucinex. The new pseudoephedrine-making process turns the substance into an unusable, jelly-like material when drug-cookers try to extract it. Story

Suggested Articles

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

Just weeks after selling the sterile manufacturing assets of its Kyowa operation in Japan, it has unloaded the rest of its Kyowa drugmaking operation.

India’s Aurobindo, which has yet to close its $1 billion deal to buy 300 Sandoz products in the U.S., continues to rack up FDA issues.